Agilent Announces Cash Dividend of 24.8 Cents per Share

2/19/25 4:05:00 PM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $A alert in real time by email

Agilent Technologies, Inc. (NYSE:A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on April 23, 2025, to all shareholders of record as of the close of business on April 1, 2025.

The timing and amounts of future dividends are subject to determination and approval by Agilent's board of directors.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company's dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties are detailed in Agilent's filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the fiscal year ended Oct. 31, 2024. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250219888217/en/

INVESTOR CONTACT:

Parmeet Ahuja

+1 408-345-8948

[email protected]

MEDIA CONTACT:

Andréa Topper

+1 408-709-0060

[email protected]

Get the next $A alert in real time by email

Recent Analyst Ratings for

Date	Price Target	Rating	Analyst
2/10/2025	$135.00 → $145.00	Underweight → Equal Weight	Barclays
8/28/2024	$157.00	Overweight	Wells Fargo
7/10/2024	$135.00 → $150.00	Neutral → Buy	Citigroup
6/27/2024		Outperform → Peer Perform	Wolfe Research
6/3/2024	$135.00	Hold	Jefferies
4/5/2024	$145.00 → $163.00	Hold → Buy	Stifel
12/13/2023	$140.00	Outperform	Wolfe Research
12/12/2023	$130.00 → $133.00	Buy → Neutral	BofA Securities

More analyst ratings

Agilent Announces Cash Dividend of 24.8 Cents per Share

Chat with this insight

Recent Analyst Ratings for $A

$A Financials

Live finance-specific insights

Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

Agilent Announces Cash Dividend of 24.8 Cents per Share

$A Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Agilent upgraded by Barclays with a new price target

Wells Fargo initiated coverage on Agilent with a new price target

Agilent upgraded by Citigroup with a new price target

$A SEC Filings

Agilent Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Agilent Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

Agilent Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

$A Press Releases

Fastest customizable press release news feed in the world

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Agilent to Announce Second-Quarter Fiscal Year 2025 Financial Results on May 28

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

$A Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Gonsalves Rodney (Amendment)

Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

$A Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Podolsky Daniel K sold $211,844 worth of shares (1,819 units at $116.46), decreasing direct ownership by 5% to 35,737 units (SEC Form 4)

V.P., Corporate Controller Gonsalves Rodney sold $232,691 worth of shares (1,908 units at $121.98), decreasing direct ownership by 8% to 21,786 units (SEC Form 4)

Amendment: V.P., Corporate Controller Gonsalves Rodney received a gift of 7,149 shares and gifted 7,149 shares, increasing direct ownership by 43% to 23,693 units (SEC Form 4)

$A Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

$A Leadership Updates

Live Leadership Updates

Agilent to Acquire North American CDMO BIOVECTRA

Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence

Recent Analyst Ratings for
$A

$A
Financials

$A
Analyst Ratings

$A
SEC Filings

$A
Press Releases

$A
Insider Purchases

$A
Insider Trading

$A
Large Ownership Changes

$A
Leadership Updates